文献速递肝病消化道肿瘤与早癌

β-catenin信号下调NKG2D配体表达并与肝细胞癌侵袭性相关

Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.
PubMed 文献 · J Hepatol · 2021-01-21

该研究在大型人肝细胞癌数据集及两种小鼠模型中分析NKG2D配体(MICA、MICB、ULBP1、ULBP2)表达,发现MICA/MICB表达与肿瘤侵袭性和患者不良预后相关,ULBP1/2在CTNNB1突变型肝癌中下调且与较好预后相关,β-catenin信号通过TCF4结合下调小鼠Rae-1配体表达。

要点

  • MICA/MICB在人类肝细胞癌中的表达与肿瘤侵袭性及患者不良预后相关。
  • ULBP1/2表达与患者不良预后相关,但在CTNNB1突变型肝癌中下调。
  • β-catenin信号通过TCF4结合下调小鼠Rae-1 NKG2D配体表达。

核心结论

  • NKG2D配体表达与侵袭性肝肿瘤发生相关,β-catenin信号下调这些配体可能解释CTNNB1突变型肝癌侵袭性较低的表型。

研究设计与样本

  • 分析大型人肝细胞癌数据集中NKG2D配体(MICA、MICB、ULBP1、ULBP2)表达,方法为Fluidigm TaqMan和RNA-seq。
  • 在两种重现人类肿瘤两大组特征的小鼠模型中分析mRNA和蛋白水平。

主要发现

  • 人类肝细胞癌中MICA和MICB配体表达与肿瘤侵袭性和患者不良预后相关。
  • ULBP1和ULBP2表达与患者不良预后相关,且在CTNNB1突变型、炎症水平低、预后较好的肝癌中下调。
  • 患者肝癌中ULBP1/2表达水平与β-catenin靶基因表达呈负相关。
  • 小鼠肝癌模型中β-catenin信号通过TCF4结合下调Rae-1 NKG2D配体(ULBPs的同源物)表达。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The NKG2D system is a potent immunosurveillance mechanism in cancer, wherein the activating NK cell receptor (NKG2D) on immune cells recognises its cognate ligands on tumour cells. Herein, we evaluated the expression of NKG2D ligands in hepatocellular carcinoma (HCC), in both humans and mice, taking the genomic features of HCC tumours into account. METHODS: The expression of NKG2D ligands (MICA, MICB, ULBP1 and ULBP2) was analysed in large human HCC datasets by Fluidigm TaqMan and RNA-seq methods, and in 2 mouse models (mRNA and protein levels) reproducing the features of both major groups of human tumours. RESULTS: We provide compelling evidence that expression of the MICA and MICB ligands in human HCC is associated with tumour aggressiveness and poor patient outcome. We also found that the expression of ULBP1 and ULBP2 was associated with poor patient outcome, and was downregulated in CTNNB1-mutated HCCs displaying low levels of inflammation and associated with a better prognosis. We also found an inverse correlation between ULBP1/2 expression levels and the expression of β-catenin target genes in patients with HCC, suggesting a role for β-catenin signalling in inhibiting expression. We showed in HCC mouse models that β-catenin signalling downregulated the expression of Rae-1 NKG2D ligands, orthologs of ULBPs, through TCF4 binding. CONCLUSIONS: We demonstrate that the expression of NKG2D ligands is associated with aggressive liver tumorigenesis and that the downregulation of these ligands by β-catenin signalling may account for the less aggressive phenotype of CTNNB1-mutated HCC tumours. LAY SUMMARY: The NKG2D system is a potent immunosurveillance mechanism in cancer. However, its role in hepatocellular carcinoma development has not been widely investigated. Herein, we should that the expression of NKG2D ligands by tumour cells is associated with a more aggressive tumour subtype.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Cadoux M, Caruso S, Pham S, et al. Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness. J Hepatol. 2021. PMID: 33484773. doi:10.1016/j.jhep.2021.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。